Ignite Creation Date:
2025-12-24 @ 11:46 AM
Ignite Modification Date:
2026-01-31 @ 7:55 AM
Study NCT ID:
NCT03608761
Status:
COMPLETED
Last Update Posted:
2018-12-04
First Post:
2018-07-09
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Comparison Between Rebamipide 2% Versus Autologous Serum
Sponsor:
Hospital Nacional Profesor Alejandro Posadas
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
055LuPeSo/15
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None